"Cardi with a cause" is at the center of a new collaboration between the nonprofit Dress for Success, O Magazine, and women's retailer Talbots, which launched Tuesday.
Five cardigans are part of the capsule collection, but women can also donate professional clothes to Talbots to participate.
CBS's Gayle King, while wearing one of the cardigans, told Cheddar the effort offers a way for women to look good in all work situations.
"It's one of those win-win-win situations," she said. "When you look good, you feel good, you do good, and that's what Dress for Success does."
This is the fifth year that Oprah Winfrey's magazine and Talbots have teamed up to benefit the cause, which aims to help women achieve economic independence.
King said the partnership has continued because of its success and because "we all actually like each other."
O Creative Director Adam Glassman said the partnership has raised over $6 million and helped 150,000 women. During the event, Talbots will donate 30 percent of proceeds to the nonprofit.
"With Dress for Success, they've figured out a way for women to look good in all social work situations and Talbots just adds to that," said King, who is also editor-at-large of O Magazine.
It's important to empower women in the workplace to pay it forward because she said research shows the inclusion of women in the workplace improves companies and helps foster better work environments.
"All the statistics show when women are involved they're more collaborative, they tend to have a really good success rate," she said.
The global chip shortage continues to weigh on the automotive industry. For example, Ford says it is suspending or cutting production at eight of its factories in North America through next week due to the shortage. Balu Balakrishnan, President and CEO of Power Integrations, joins Cheddar News' Closing Bell, where he elaborates on why the chip shortage has dragged into 2022.
Peloton has weathered a seemingly never-ending storm the past few months: PR blunders, sinking customer demand, and in recent weeks, reported cost-cutting and potential layoffs. Now, several companies are said to be in the mix as potential buyers: Amazon, Netflix, Disney, and Apple. How likely is it that one of these companies pursues a deal — and how likely is it that it will be Apple who buys Peloton? Dan Ives, Managing Director of Equity Research at Wedbush Securities, joins Closing Bell to discuss his thoughts about Apple pursuing a Peloton takeover,
Astra aborted the launch for NASA ELaNa 41 Mission out of Cape Canaveral on Monday due to what was described as a minor issue, but the company's stock fell nearly 14 percent following the news. Jim Cantrell, CEO and co-founder of Phantom Space, which builds and launches spacecraft of its own, joined Cheddar to discuss the scrubbed mission. “The last thing you want is for this to go wrong, you're better to err on the side of safety expectations,” Cantrell explained, noting that the mission delay was a normal event.
Dating app Bumble announced its first acquisition, expanding into Europe by picking up Fruitz, a French Platform. The Fruitz app allows its users to convey dating preferences through fruit metaphors.
Meat production giant Tyson Foods reported a beat on its Q1 earnings. In spite of obstacles posed by supply chain issues and inflation, the company exceeded expectations on earnings per share and revenue.
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
